Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy

被引：0

作者：

R. H. Enting

P. Portegies

机构：

[1] Department of Neurology,

[2] Academic Medical Center H2-214,undefined

[3] Meibergdreef 9,undefined

[4] 1105 AZ,undefined

[5] Amsterdam,undefined

[6] The Netherlands e-mail: P.Portegies@amc.uva.nl Tel.: +31-20-5663842 Fax: +31-20-6971438,undefined

来源：

Journal of Neurology | 2000年 / 247卷

关键词：

Key words Progressive multifocal leukoencephalopathy; Anti-HIV agents; Cytarabine; HIV infection;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We assessed survival in AIDS-related progressive multifocal leukoencephalopathy (PML) and the effect of cytarabine and antiretroviral therapy in a retrospective analysis of a series of consecutive 35 patients with AIDS-related PML in an academic AIDS referral center over ¶15 years. Treatment regimens consisted of highly active antiretroviral treatment (HAART), intravenous cytarabine, or both. Median survival after diagnosis in the overall series was 88 days. Patients with low CD4 cell count tended to have shorter survival. Seven patients (20%) had prolonged survival (> 1 year). Cytarabine did not affect survival. Seven patients were treated with HAART, which did not significantly improve survival. We conclude that the prognosis of AIDS-related PML is still poor, with a median survival of ¶3 months.

引用

页码：134 / 138

页数：4

共 50 条

[21] Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy
Herrero-Romero, M
Cordero, E
López-Cortés, LF
de Alarcón, A
Pachón, J
AIDS, 2001, 15 (06) : 809 - 809
[22] Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma
Tavio, M
Nasti, G
Spina, M
Errante, D
Vaccher, E
Tirelli, U
ANNALS OF ONCOLOGY, 1998, 9 (08) : 923 - 923
[23] HIV-related lung cancer in the era of highly active antiretroviral therapy
Bower, M
Powles, T
Nelson, M
Shah, P
Cox, S
Mandelia, S
Gazzard, B
AIDS, 2003, 17 (03) : 371 - 375
[24] Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS
Moreno, S
Miralles, P
Diaz, MD
Berenguer, J
deQuiros, JCLB
Blazquez, R
Cosin, J
Bouza, E
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) : 1066 - 1068
[25] FAILURE OF CYTARABINE INTERFERON THERAPY IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
HEIDE, W
KOMPF, D
REUSCHE, E
BODEMER, M
WEBER, T
ANNALS OF NEUROLOGY, 1995, 37 (03) : 412 - 413
[26] Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy
Berenguer, J
Miralles, P
Arrizabalaga, J
Ribera, E
Dronda, F
Baraia-Etxaburu, J
Domingo, P
Márquez, M
Rodriguez-Arrondo, FJ
Laguna, F
Rubio, R
Rodrigo, JL
Mallolas, J
de Miguel, V
CLINICAL INFECTIOUS DISEASES, 2003, 36 (08) : 1047 - 1052
[27] The Prognosis of Progressive Multifocal Leukoencephalopathy in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment: A Systematic Review
Aye, Soe Lwin
Trivedi, Yash
Bolgarina, Zoryana
Desai, Heet N.
Senaratne, Mithum
Swami, Shivling S.
Mohammed, Lubna
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
[28] Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV)
Robinson, LG
Chiriboga, CA
Champion, SE
Ainyette, I
DiGrado, M
Abrams, EJ
JOURNAL OF CHILD NEUROLOGY, 2004, 19 (01) : 35 - 38
[29] Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy
Baqi, M
Kucharczyk, W
Walmsley, SL
AIDS, 1997, 11 (12) : 1526 - 1527
[30] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY - REMISSION WITH CYTARABINE
MARRIOTT, PJ
OBRIEN, MD
MACKENZIE, ICK
JANOTA, I
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1975, 38 (03): : 205 - 209

← 1 2 3 4 5 →